The second China Obesity Congress (COC) was held in Beijing on July 29-30, 2023. The event was co-hosted by the National Clinical Research Center for Digestive Diseases and the Beijing Medical Association Weight Loss and Metabolism Specialist Branch. The congress was attended by many experts from surgery, endocrinology, cardiology, nutrition, and biology.

Obesity is a global health challenge. Prof. Zhongtao Zhang, chairman of the COC and vice president of Beijing Friendship Hospital, highlighted that weight loss and metabolic surgery in China faces two challenges: how to expand high-quality medical resources and how to improve clinical specialty and medical quality.

Bariatric surgery requires high standards for the medical industry. Medical quality and safety are critical, especially for staplers. IntoCare, an innovator of Intelligent Powered Stapling Platform, participated in the China Obesity Congress and provided solutions for weight loss surgery. It demonstrated its platform product features and clinical effects. Mrs. Eva Zhang, founder and CEO of IntoCare, spoke at the CEO Forum. She stressed that innovation based on demand is the key to medical technology development. She advocated for forward-looking and subversive innovation in the field of medical devices.

IntoCare is a medical technology company with core R&D capabilities. Its first product, “The X-in-One” Intelligent Powered Stapling Platform, is an industry-disruptive innovation. As a Chinese-made stapler, it can improve weight loss and metabolic surgery, enhance quality and safety, and offer effective solutions for obese patients. IntoCare also aims to address future needs and create hope. However, innovation faces many challenges such as business model, investment, operation, profit, and talent. We are climbing a peak but we see the road ahead.

IntoCare Intelligent Powered Stapling Platform allow users to change different stapler working head without powered handles. This saves resources, costs, and waste, and advances medical device technology innovation. IntoCare's products care for doctors, patients, and the industry's sustainability.

At the COC2023 China Obesity Congress, IntoCare showed its support for medical exchange, innovation, and health strategy. The company will keep innovating medical device design, following the "from demand to creation" concept. It will promote the medical device field's development, meet market needs, and contribute to the industry's sustainable upgrading.